Keros Therapeutics, Inc.

KROS

A reverse discounted cash flow for Keros Therapeutics, Inc. needs a live price.

That is the one figure on this site that costs money to fetch, so it runs on an account rather than on a page anybody can open. It starts from what the company has actually filed: the 2025 revenue and margin on its own statements. It asks what growth the current price is already assuming.

Valuation

Seeded from KROS’s own filed revenue, margin and trading multiples, against a live price. An account is what lets this run, for the reason above.

Low · XXX×

XXX

Implied market cap: XXX
Total change: XXX
Annualised: XXX

Base · XXX×

XXX

Implied market cap: XXX
Total change: XXX
Annualised: XXX

High · XXX×

XXX

Implied market cap: XXX
Total change: XXX
Annualised: XXX

Run the numbers on Keros Therapeutics, Inc. yourself.

Ten seconds. No card. Nothing to cancel.

Free 3-day Measure trial·No card, no broker connection.

Email address

Continue with Google

What an account lets you do with Keros Therapeutics, Inc.

Run the model forward, then flip it
Set the assumptions for Keros Therapeutics, Inc. (margin, growth, multiple) and see the price they produce. Three runs free on this account, ever, no card.
Hold the price, solve for growthMeasure
See every filed year, not just the recent ones
The statements this company has actually filed, in the way it filed them.
Every year on recordMeasure
Ask about any of it, get the filing back
The assistant answers from this company's own statements, and links every figure straight to its source.

Create a free account See what the paid plans add

Free, no card, and it does not expire.